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The use of different assay conditions has complicated the evaluation of studies relating salivary lysozyme
levels to oral or systemic disease. The purpose of this study was to compare values obtained for lysozyme
activity in mixed saliva of 104 healthy subjects by using two assay techniques and four variations in sample
preparation. Lysozyme activity was assayed by the turbidimetric and lysoplate methods with human colostrum
lysozyme as the standard. Lysozyme activity in saliva samples made 0.5 M with respect to NaCl was compared
with that in untreated samples with and without centrifugation. Mean values for lysozyme concentration in
centrifuged saliva were 2.2 pg/ml with the turbidimetric assay and 5.9 ,g/ml with the lysoplate assay. In
samples which were salt treated before centrifugation, mean concentrations increased to 17.3 and 72.9 ,ug/ml,
respectively. The results for uncentrifuged saliva were four to five times higher than the results for centrifuged
saliva in each of the assay systems. Salt treatment without centrifugation produced values comparable to those
obtained with centrifugation. The addition of salt to human colostrum or hen egg white lysozyme generally
resulted in a 20 to 25% increase in expressed activity. These results indicate that (i) the measurement of
lysozyme in the supernatant of centrifuged saliva is of questionable value, (ii) most of the lysozyme in whole
saliva is inactive and may be activated by markedly increasing the ionic strength, and (iii) values for lysozyme
activity in whole saliva are much greater in the lysoplate assay than in the turbidimetric assay when the same
standard is used.
It has long been suggested that the presence of lysozyme
in biological fluids such as saliva is an important factor in the
nonspecific defense mechanisms of the body against micro-
bial invasion. However, the precise role of lysozyme in these
defense mechanisms and, indeed, the importance of
lysozyme have remained elusive (4). There has been a
significant amount of effort on the part of various investiga-
tors to relate differences in the concentration of lysozyme in
human saliva to various oral or systemic disease states (1, 2).
Attempts to evaluate the results from any one study in terms
of those obtained from another study on the same
pathophysiology have been frustrated by the lack of use of a
single assay system and by the use of different standard
lysozyme preparations.
In general, two assays, a turbidimetric assay (10, 11) and
the lysoplate technique (7), have been used. They have in
common the use of the same biological event, the lysis of
"Micrococcus lysodeikticus." Studies on blood serum
which have compared the two assays for the measurement of
lysozyme concentration in the same serum samples have
yielded divergent results (3, 9), reflecting differences in the
techniques. Similar comparisons are not available for saliva.
The interaction of lysozyme with components such as
bacteria, bacterial cell wall fragments, and proteins, such as
mucins, which are found in saliva, has been suggested to
present a problem in the accurate determination of lysozyme
colicentration in saliva (13). Several studies have suggested
the use of a mild acid treatment of whole saliva or parotid
saliva to dissociate such complexes before assay (8, 14).
Other investigators have used an immunologically based
assay which is not dependent on the expression of biological
activity to determine the concentration of lysozyme in saliva
(12). Because the level of active lysozyme may be more
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relevant for elucidating a defensive role for this protein, an
assay that differentiates between active and inactive
lysozyme in saliva would provide meaningful results.
The purpose of this study was to directly compare the
levels of lysozyme measured with either a turbidimetric
assay or the lysoplate assay in human saliva and to evaluate
a method not involving the relatively slow and drastic
change in pH suggested by other investigators to be neces-
sary for the accurate measurement of total lysozyme activity
in saliva.
MATERIALS AND METHODS
Saliva collection and sample preparation. Whole saliva was
collected from 104 subjects by paraffin stimulation. A 1-ml
portion of each sample was frozen and stored at -20°C for
subsequent lysozyme assays. Before the assays, the sample
was divided in half, and one portion was diluted with an
equal portion of 1.0 M NaCl. The portions were further
divided, and half of each (250 1.l of saliva) was centrifuged at
5,000 x g in a Fisher Microfuge for 4 min at 4°C. Thus, for
each subject four separate assay samples were obtained: (i)
the original whole saliva, (ii) whole saliva after salt treat-
ment, (iii) the supernatant fraction from centrifuged whole
saliva, and (iv) the supernatant fraction from centrifuged
salt-treated whole saliva.
Lysozyme assays. Each sample was assayed in duplicate by
both the lysoplate and the turbidimetric technique. The
results were expressed in micrograms of lysozyme per
milliliter of starting whole saliva based on comparison with
the activity of human colostrum lysozyme (Sigma Chemical
Company, St. Louis, Mo.). Standard solutions were pre-
pared by dissolving the respective lysozyme preparation in
deionized water. The protein concentration was established
by spectroscopy. Stock solutions of standards of 200 to 250
,ug/ml were prepared and stored at 4°C. Independent dilu-
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FIG. 1. Activity of human colostrum lysozyme and hen egg white lysozyme. (a) Lysoplate assay; (b) turbidimetric assay. A, Colostrum
lysozyme; 0, hen egg white lysozyme. For the turbidimetric assay, one unit of activity was defined in terms of the amount of lysozyme which
caused a decrease of 0.001 A490 U/min at 25'C. Points represent means of triplicate assays from 11 series of experiments. Lines were derived
by linear regression (r2 > 0.98).
tions ranging from 8 to 84 jug/ml were made for each series of
assays, and the same dilutions were used for both the
lysoplate and the turbidimetric assay. Four dilutions, rang-
ing from 12.5 to 100 jig/ml, of hen egg white lysozyme
(Worthington Diagnostics, Freehold, N.J.) were also in-
cluded in each assay series. These standards were prepared
in the same manner as the human colostrum lysozyme
standards. Concentrations of standards were selected to
accommodate the range of lysozyme activity expected for
the whole saliva samples. In both assays, reference curves
established with these concentrations exhibited strong lin-
earity (Fig. 1). Hen egg white lysozyme activity was approx-
imately 40% that of human colostrum lysozyme, and this
relationship was consistent in both assays.
Lysoplate assay. Lysoplates were prepared as described by
Osserman and Lawlor (7) by using 1% agarose (type I, low
EEO; Sigma) and "M. lysodeikticus" cells (Worthington).
Portions (5 RI) of the samples or standards were placed in the
2-mm wells, and the lysoplates were incubated for 18 h at
room temperature (23 to 25°C). Diameters of lysis zones
were determined directly with a dial caliper (Mitutoya;
obtained from Laboratory Supplies Co., Hicksville, N.Y.)
accurate to 0.02 mm. The results for standards were plotted
on a semilogarithmic graph, and the values for samples were
extrapolated from this reference curve.
Turbidimetric assay. The turbidimetric assays were per-
formed by using a Kontron 810/820 UV-VIS Spectrophotom-
eter essentially as described by Shugar (10), except that the
wavelength of measurement was 490 nm. This wavelength
was selected to provide a useful compromise between sen-
sitivity and accuracy, as discussed by Morsky (6). A 10-,lI
portion of the samples or standards was added to a 990-pA
portion of a suspension of "M. lysodeikticus" cells (30 mg of
dried cells suspended in 100 ml of 0.1 M sodium phosphate
[pH 7.0] by stirring for 1 h at room temperature). In
situations, such as with centrifuged saliva, in which low
activity was observed, the assay was repeated with a 25-,ul
portion of the sample with 975 RI of substrate. The decrease
in optical density was monitored at 490 nm as a function of
time by using a chart recorder. The slope of the line was
measured from the first 2 to 5 min of reaction. One unit was
defined as the amount of lysozyme activity required to cause
a decrease of 0.001 A49 U/min at 25'C. Lysozyme values for
samples were converted to micrograms per milliliter by using
the reference curve established with standard lysozyme
preparations.
Control experiments. A separate control experiment was
conducted to determine the effect of increased ionic strength
on the lysozyme activity of the standard preparations of
human colostrum lysozyme and hen egg white lysozyme. In
this experiment, 0.5 M NaCl was used as the diluent in place
of deionized water, making the solutions equivalent to the
salt-treated saliva samples in ionic strength. Activity was
compared with that of the regular standard preparations over
the same range of concentrations in deionized water. There
was generally somewhat greater activity (20 to 25%) in both
assays with the salt-treated standards than with the same
standards in deionized water. The addition of 0.5 M NaCl
alone to either assay system in the absence of sample or
standard did not result in activity.
Because diluted saliva samples were being compared with
undiluted samples, several saliva samples were diluted with
water or were made 0.5 M with respect to NaCl by the
addition of solid salt. The results obtained were equivalent to
those with undiluted saliva and with saliva samples diluted
with 1.0 M NaCl, respectively.
To compare the salt treatment method with the acid
treatment method described by Virella and Goudswaard
(13), additional saliva samples were treated in the following
manner. A portion of whole saliva was taken into the whole,
salt-treated whole, centrifuged, and centrifuged salt-treated
fractions as described above. A second portion was placed in
dialysis against 0.1 M Tris acetate (pH 4.5; Spectrapor 8,000-
to 10,000-molecular-weight membranes) for 1 h at room
temperature. A portion of this material was removed, and
the pH was raised to 7.5 by the addition of solid Tris base.
The remaining material was subjected to centrifugation at
10,000 x g for 10 min at 4°C, and the supernatant fraction
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TABLE 1. Lysozyme activity in mixed saliva according to sample preparation and assay techniquea
Amt of lysozyme (,ug/ml of saliva)' by indicated assay technique
Sample
prepnb Lysoplate Turbidimetric
Mean ± SD Median (range) Modal value Mean ± SD Median (range) Modal value
W 22.7 ± 23.7 14.0 (1.2-130.0) 8.5 11.1 ± 6.3 10.5 (1.3-34.2) 10.5
WS 79.9 ± 86.9 54.0 (1.3-505.0) 11.5 17.9 ± 11.1 16.3 (1.5-50.0) 6.5
C 5.9 ± 9.3 2.7 (0.5-64.0) 0.8 2.2 ± 1.6 1.7 (0.7-10.8) 1.0
CS 72.9 ± 84.2 43.0 (1.6-580.0) 36.0 17.3 ± 11.2 15.5 (1.5-46.6) 6.7
a Human colostrum lysozyme was used as the standard in both assays.
b W, Uncentrifuged whole saliva; WS, uncentrifuged salt (0.5 M)-treated saliva; C, supernatant of centrifuged whole saliva; CS, supernatant of centrifuged salt-
treated whole saliva.
C Values were obtained from the assay of saliva from 104 subjects. All assays were performed in duplicate.
was neutralized as described above. These various samples
were compared in the same assay series by both the
turbidimetric and the lysoplate method.
Analysis of results. Means and standard deviations of
lysozyme activity in the saliva from the 104 subjects were
calculated for each sample preparation and assay method.
Modal values were also determined.
The distribution of values was tested for normality by
using the Kalmogorov-Smirov procedure. The values ob-
tained in the lysoplate assay for all of the variations of
sample preparation were skewed to the right, with their
modes over a lower value. Transformation to logarithms
resulted in a normal distribution for all sets of values.
Turbidimetric results, although distributed too uniformly
and too flatly to be exactly normal, were close enough to
normality to use untransformed. Pearson product-moment
correlation coefficients were determined between sample
preparations and between the two assay methods. Because
some distributions were not exactly normal, nonparametric
Spearman rank correlation coefficients were also deter-
mined.
RESULTS
The results obtained for the individual saliva samples are
shown in Table 1, and the Pearson correlation coefficients
for the different saliva sample preparations are shown in
Table 2.
By both assays, lysozyme activity was reduced by 75 to
80% in saliva samples directly centrifuged under our condi-
tions. Salt treatment of whole saliva increased detectable
lysozyme activity by more than threefold in the lysoplate
TABLE 2. Pearson product-moment correlation coefficients
between variations in saliva sample preparation
Correlation coefficient' by indicated
compared' assay method
Lysoplate Turbidimetric
W vs WS 0.860c 0.900C
W vs C 0.607C 0.193d
W vs CS 0.861C 0.904c
C vs WS 0.469c 0.163e
C vs CS 0.460c 0.160e
CS vs WS 0.952c 0.904C
a W, Uncentrifuged whole saliva; WS, uncentrifuged salt (0.5 M)-treated
saliva; C, supernatant of centrifuged whole saliva; CS, supernatant of
centrifuged salt-treated whole saliva.
b Correlation coefficient between logarithms of lysoplate results and initial
units of turbidimetric results.
c P = 0.0001.
d p = 0.0395.
e Not significant.
assay and by approximately half this proportion (1.6) in the
turbidimetric assay. In both assays, significant correlations
were observed between values obtained for uncentrifuged
whole, uncentrifuged salt-treated, and centrifuged salt-
treated samples. In the lysoplate assay, correlation coeffi-
cients ranged from 0.860 to 0.952 for these samples. Coeffi-
cients were comparable for turbidimetric results. In all
cases, P values were 0.0001. Centrifuged samples exhibited
significant (P = 0.0001) correlation with other samples in the
lysoplate assay, but the coefficients were lower than be-
tween the other samples. In the turbidimetric assay, the
centrifuged samples correlated significantly only with the
uncentrifuged whole saliva samples, but the coefficient was
quite low.
The results obtained with the lysoplate assay were consis-
tently higher than those obtained with the turbidimetric
assay. This difference was two- to threefold for the whole
and centrifuged fractions but increased to four- to fivefold
for the salt-treated fractions. The Pearson product-moment
coefficients of correlation between logarithms of lysoplate
results and initial units of turbidimetric results were 0.567 for
uncentrifuged whole saliva, 0.721 for uncentrifuged salt-
treated saliva, 0.527 for centrifuged whole saliva superna-
tant, and 0.776 for centrifuged salt-treated whole saliva
supernatant. The values obtained from the two assays were
significantly correlated for all of the sample preparations (P
= 0.0001).
Spearman rank correlation coefficients are not shown.
These values were within +0.05 of the Pearson scores,
except for correlation of the centrifuged whole saliva super-
natant values in the turbidimetric assay. These coefficients
TABLE 3. Lysozyme activity in human mixed saliva after acid or
salt treatmenta
Amt of lysozyme (pLg/ml of saliva) in samples
Assay method that were:
and sample
Untreated Salt treatedb Acid treatedc
Lysoplate
Whole 16.3 27.3 20.0
Centrifuged 8.9 28.8 23.3
Turbidimetric
Whole 6.4 9.3 10.3
Centrifuged 3.4 10.1 9.3
a Human colostrum lysozyme was used as the standard.
b Whole saliva was diluted 1:1 with 1.0 M NaCI.
c Whole saliva was dialyzed against 0.1 M Tris acetate (pH 4.5) for 1 h. The
whole saliva sample was removed before centrifugation and neutralized with
solid Tris. The centrifuged sample was obtained by neutralization of the
supernatant fraction after centrifugation.
VOL. 24, 1986
966 JENZANO ET AL.
were about 0.10 higher than the Pearson scores and were
significant (P = 0.0112 to 0.0001) for all comparisons.
In the saliva samples subjected to treatment with 0.1 M
Tris acetate (pH 4.5) before assay, the values for lysozyme
activity were comparable to those obtained when the same
whole saliva samples were mixed 1:1 with 1.0 M NaCl before
assay (Table 3).
DISCUSSION
It is clear based on our results that the assessment of
lysozyme activity in human whole saliva is influenced by a
number of factors. Several of these factors were investigated
in this study. Of particular importance is that our observa-
tions represent the first direct comparison of the effects of
these factors on the same set ofhuman whole saliva samples.
Assay methods and standards. The values for lysozyme
concentration for all saliva samples were higher with the
lysoplate assay than with the turbidimetric assay. These
results were obtained by using an identical standard human
lysozyme preparation in both assay systems. Greater values
with the lysoplate assay as compared with the turbidimetric
assay were also obtained by Klass and co-workers (5) for
lysozyme concentration in blood serum but with hen egg
white lysozyme as the standard for both assay systems.
Under our assay conditions, the relative activities of human
colostrum lysozyme and hen egg white lysozyme were
similar for both assays. A strong linear relationship oc-
curred, with concentrations of 8 to 84 ,ug/ml for human
colostrum lysozyme and 12.5 to 100 ,ug/ml for hen egg white
lysozyme. Consequently, either standard should be appro-
priate to obtain relative lysozyme activity in test samples in
either the lysoplate or the turbidimetric assay system in the
absence of any other factors which might differentially affect
lysozyme activity.
Because the use of the same lysozyme standard (either
human or hen egg white) yielded markedly different values
for the concentration of lysozyme in saliva in the two assay
systems, it is apparent that the observed activity of
lysozyme in human saliva was influenced by the assay
conditions in one or both of the systems. This quality of
effect has been observed with the assay of lysozyme in blood
(3, 5, 9, 15). In the absence of rigorous structural analysis of
human salivary lysozyme, it is possible that there are mo-
lecular differences not detected by polyclonal antibodies
which result in different activity in the two assay systems
under our experimental conditions. Although this is unlikely,
it must be considered until more information regarding the
molecular properties of the human salivary protein is avail-
able. A more likely possibility is that there are substances in
human saliva which differentially affect the observed activity
of the enzyme in the two assay systems. Our laboratory
recently saw such effects with amines and polyamines (J. W.
Jenzano and R. L. Lundblad, abstr. 298, Annu. Meet. Int.
Assoc. Dental Res., 1986).
Sample preparation. Values for lysozyme activity in saliva
were greatly reduced in our study if the whole saliva was
centrifuged before assay and the supernatant fraction was
used as the sample, such that lysozyme activity was only 20
to 25% that of whole untreated saliva. Furthermore, corre-
lation of these values with those of the other variations of
sample preparation was low. Apparently, a considerable
amount of active lysozyme is removed by centrifugation,
and the factors responsible for the apparent binding and
removal of lysozyme appear to be separate variables, such
that the resulting information has questionable value.
The treatment of whole saliva with 0.5 M NaCl increased
measurable lysozyme activity in both of the assay systems.
The difference between the values obtained before and after
salt treatment could reflect the amount of the enzyme in the
oral environment that is inactive or unavailable because of
binding to other salivary constituents, such as mucins or
bacterial cells. A similar argument was previously advanced
by Virella and Goudswaard (13) and by Virella and co-
workers (14). The values obtained by salt treatment in the
present study (the uncentrifuged salt-treated saliva values)
exhibited high correlation with those for untreated saliva and
were not significantly altered if the samples were subse-
quently centrifuged and the supernatant fractions were used
as samples in either assay system. The results with salt
treatment were comparable to those obtained with the more
complex procedure of pH adjustment by dialysis against pH
4.5 Tris acetate (13). Of particular note is that for salt-treated
samples, a comparison of lysoplate and turbidimetric results
showed that the magnitude of the increase was much greater
with the lysoplate assay. Although some of the difference
may reflect a modest effect of increased ionic strength on the
activity of lysozyme in the two assays, it is apparent that
other factors influenced the observed lysozyme activity. The
difference between the centrifuged and centrifuged salt-
treated saliva values in Table 1 most likely reflects the
activation of bound lysozyme in whole saliva and probably
provides a reasonable estimate of the total lysozyme activity
in saliva which can be assayed by the lysis of "M.
Iysodeikticus" in either assay system.
Conclusions. (i) The lysoplate assay provides higher values
for lysozyme concentration in human saliva than does the
turbidimetric assay with either human colostrum lysozyme
or hen egg white lysozyme as the standard in each assay.
(ii) The use of human colostrum lysozyme instead of hen
egg white lysozyme in both the turbidimetric and the lyso-
plate assay system gives lower values for lysozyme concen-
tration in human saliva.
(iii) The value for lysozyme concentration in the superna-
tant fraction obtained by the centrifugation of untreated
whole human saliva both is low with respect to the amount of
lysozyme in whole saliva and appears to be unreliable with
respect to values obtained with the treatment of whole
saliva.
(iv) Treatment of whole saliva with 0.5 M NaCl increases
the amount of lysozyme available for assay in both the
turbidimetric and the lysoplate system.
(v) Evaluation of the results of studies relating to changes
in lysozyme concentration in whole saliva must involve the
consideration of assay methods, standards used, and sample
preparation.
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